392 related articles for article (PubMed ID: 10503998)
21. Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study.
Bogazzi F; Bartalena L; Cosci C; Brogioni S; Dell'Unto E; Grasso L; Aghini-Lombardi F; Rossi G; Pinchera A; Braverman LE; Martino E
J Clin Endocrinol Metab; 2003 May; 88(5):1999-2002. PubMed ID: 12727944
[TBL] [Abstract][Full Text] [Related]
22. Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone.
Minelli R; Gardini E; Bianconi L; Salvi M; Roti E
J Endocrinol Invest; 1992 Dec; 15(11):853-5. PubMed ID: 1291598
[TBL] [Abstract][Full Text] [Related]
23. Amiodarone-induced thyroid dysfunction in an iodine-replete area: epidemiological and clinical data.
Zosin I; Balaş M
Endokrynol Pol; 2012; 63(1):2-9. PubMed ID: 22378090
[TBL] [Abstract][Full Text] [Related]
24. Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality.
O'Sullivan AJ; Lewis M; Diamond T
Eur J Endocrinol; 2006 Apr; 154(4):533-6. PubMed ID: 16556715
[TBL] [Abstract][Full Text] [Related]
25. Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations.
Dietlein M; Schicha H
Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):145-51. PubMed ID: 15789273
[TBL] [Abstract][Full Text] [Related]
26. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
Diehl LA; Romaldini JH; Graf H; Bartalena L; Martino E; Albino CC; Wiersinga WM
Clin Endocrinol (Oxf); 2006 Oct; 65(4):433-8. PubMed ID: 16984234
[TBL] [Abstract][Full Text] [Related]
27. Amiodarone and the thyroid.
Jabrocka-Hybel A; Bednarczuk T; Bartalena L; Pach D; Ruchała M; Kamiński G; Kostecka-Matyja M; Hubalewska-Dydejczyk A
Endokrynol Pol; 2015; 66(2):176-86. PubMed ID: 25931048
[TBL] [Abstract][Full Text] [Related]
28. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism.
Trip MD; Wiersinga W; Plomp TA
Am J Med; 1991 Nov; 91(5):507-11. PubMed ID: 1951413
[TBL] [Abstract][Full Text] [Related]
29. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
30. AMIODARONE AND THYROID DYSFUNCTION.
Medić F; Bakula M; Alfirević M; Bakula M; Mucić K; Marić N
Acta Clin Croat; 2022 Aug; 61(2):327-341. PubMed ID: 36818930
[TBL] [Abstract][Full Text] [Related]
31. A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis.
Erdogan MF; Güleç S; Tutar E; Başkal N; Erdogan G
Thyroid; 2003 Feb; 13(2):205-9. PubMed ID: 12699596
[TBL] [Abstract][Full Text] [Related]
32. Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism.
Hofmann A; Nawara C; Ofluoglu S; Holzmannhofer J; Strohmer B; Pirich C
Wien Klin Wochenschr; 2008; 120(15-16):493-8. PubMed ID: 18820854
[TBL] [Abstract][Full Text] [Related]
33. Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy.
Bogazzi F; Aghini-Lombardi F; Cosci C; Lupi I; Santini F; Tanda ML; Miccoli P; Basolo F; Pinchera A; Bartalena L; Braverman LE; Martino E
J Endocrinol Invest; 2002 Feb; 25(2):176-80. PubMed ID: 11929091
[TBL] [Abstract][Full Text] [Related]
34. [Amiodarone-associated thyroid dysfunction: prevalence and possibilities of correction].
Serdiuk SE; Bakalov SA; Soboleva VA; Golitsin SP; Molashenko NV; Platonova NM; Sviridenko NIu
Kardiologiia; 2004; 44(10):32-8. PubMed ID: 15477787
[TBL] [Abstract][Full Text] [Related]
35. Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter.
Liang YL; Huang SM; Peng SL; Hsiao SH; Hung HC; Ou HY; Wu TJ
Ann Pharmacother; 2009 Jan; 43(1):134-8. PubMed ID: 19109209
[TBL] [Abstract][Full Text] [Related]
36. [A rare cause of thyreotoxicosis].
Sauer-Schulz A; Müssig K; Kurth R; Fend F; Teichmann R; Schnauder G
Dtsch Med Wochenschr; 2010 Sep; 135(37):1798. PubMed ID: 20824601
[TBL] [Abstract][Full Text] [Related]
37. Amiodarone and thyroid.
Eskes SA; Wiersinga WM
Best Pract Res Clin Endocrinol Metab; 2009 Dec; 23(6):735-51. PubMed ID: 19942150
[TBL] [Abstract][Full Text] [Related]
38. Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis.
Roti E; Minelli R; Gardini E; Bianconi L; Gavaruzzi G; Ugolotti G; Neri TM; Braverman LE
J Clin Endocrinol Metab; 1992 Nov; 75(5):1273-7. PubMed ID: 1331165
[TBL] [Abstract][Full Text] [Related]
39. Resistant type 2 amiodarone-induced thyrotoxicosis responsive to cholestyramine as an adjunctive therapy.
Rummaan A; Maryam M; Ali A; Mandal S; Saeed T
Clin Med (Lond); 2021 Sep; 21(5):e529-e530. PubMed ID: 34507939
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association.
Bartalena L; Wiersinga WM; Tanda ML; Bogazzi F; Piantanida E; Lai A; Martino E
Clin Endocrinol (Oxf); 2004 Oct; 61(4):494-502. PubMed ID: 15473883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
